Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data
Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The data, however, is yet to be peer-reviewed.
![Gadgets 360 With Technical Guruji: Ask TG [February 22, 2024]](https://c.ndtvimg.com/2025-02/dtk1rko_ask-tg_160x120_22_February_25.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Ask TG [February 22, 2024]")
